Browsing Category
Healthcare Industry News
2513 posts
This quiet IKS Health deal may reveal where Inventurus Knowledge Solutions (NSE: IKS) wants to win next
Inventurus Knowledge Solutions Limited is expanding IKS Health’s patient access AI stack through ThinkDTM and Certilytics. Read what it means now.
Optiscan Imaging (ASX: OIL) files FDA dossier for InSpecta veterinary device, targeting an $11.9bn market
Optiscan Imaging (ASX: OIL) has filed its FDA dossier for InSpecta, targeting the US$11.9bn U.S. veterinary market. Read what this milestone means for investors.
NAVER expands healthcare AI thesis with follow-on investments in Nuvilab and Soundable Health
NAVER D2SF has backed Nuvilab and Soundable Health again. Read why these AI healthcare bets matter for U.S. hospitals, data capture, and growth.
4DMedical (ASX: 4DX) secures CE Mark for CT:VQ and raises A$83m to accelerate European commercial launch
4DMedical (ASX: 4DX) secures CE Mark for CT:VQ and raises A$83M to fund EU expansion. Read what this means for investors and the respiratory imaging sector.
Is Firefly Neuroscience, Inc. building a scalable AI diagnostics platform through U.S. defense healthcare partnerships? (NASDAQ: AIFF)
Firefly Neuroscience, Inc. enters defense healthcare with AI brain tech. Find out how this partnership could reshape neurodiagnostics markets.
Spectral Medical (TSX: EDT) posts C$2.44m revenue as PMA submission slips to May 2026 and derivative liabilities widen the reported loss
Spectral Medical (EDT) reports C$2.44M revenue and shifts PMX PMA submission to May 2026. Tigris trial data in The Lancet strengthens FDA case. Read more.
Bridgepoint and Triton walk away from Spire Healthcare (LSE: SPI) as board keeps formal sale process alive with remaining bidders
Bridgepoint and Triton have walked away from Spire Healthcare's sale process. Find out what it means for SPI shareholders and what happens next. Read more.
Verana Health and Guardant Health link genomics and real-world data to accelerate precision oncology drug
Verana Health and Guardant Health (GH) combine EHR and genomic data to accelerate oncology drug development. Read the full strategic analysis.
Abbott (ABT) closes $21bn Exact Sciences deal, making it the leader in U.S. cancer screening diagnostics
Abbott (ABT) closes its $21bn Exact Sciences acquisition, creating a $12bn+ diagnostics leader in cancer screening and precision oncology. Read the full analysis.
Resonetics closes Resolution Medical deal, targeting full-stack dominance in neuromodulation and structural heart
Resonetics completes acquisition of Resolution Medical, adding biosimulation and finished device assembly to its neuromodulation and structural heart platform. Read the full analysis.